Reposar, Jhon Rey B.

HRN: 07-39-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2023
CEFUROXIME 750MG (VIAL)
01/25/2023
02/01/2023
IV
750 Mg
Q8
UTI
Waiting Final Action 
01/28/2023
CEFTRIAXONE 1G (VIAL)
01/28/2023
02/04/2023
IV
1G
Q12
T/C Typhoid Fever
Waiting Final Action 
01/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2023
02/09/2023
IV
1g
Q6
Sepsis
Waiting Final Action 
02/05/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/05/2023
02/10/2023
PO
1 Tab
OD
PCAP-C; Bacterial Infection, Unspecified
Waiting Final Action 
02/10/2023
CEFTAZIDIME 1GM (VIAL)
02/10/2023
02/27/2023
IV
1g
Q8hrs
PCAP
Waiting Final Action 
02/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2023
02/19/2023
IVT
400mg
Od
Sepsis
Waiting Final Action 
02/14/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/14/2023
02/21/2023
IV
210mg
Q6hrs
Sepsis
Waiting Final Action 
02/14/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/14/2023
02/21/2023
IV
300mg
Loading Dose
Sepsis
Waiting Final Action 
02/14/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/14/2023
02/24/2023
IV
150mg
Q24hrs
Sepsis
Waiting Final Action 
02/15/2023
CEFTAZIDIME 1GM (VIAL)
02/15/2023
02/17/2023
IV
1 Gram
Q8
T/C Sepsisi
Waiting Final Action 
02/25/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
02/25/2023
03/03/2023
PO
6ml
TID
UTI
Waiting Final Action 
02/25/2023
CIPROFLOXACIN 500MG (TAB)
02/25/2023
03/03/2023
PO
500mg
BID
Sepsis
Waiting Final Action 
02/26/2023
MUPIROCIN 2%, 15G (TUBE)
02/26/2023
03/04/2023
TOPICAL
N/A
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: